Reporting from ECCMID17, we spoke to William Irving about his current work on hepatitis C and his thoughts on the future of this field.
Browsing: Clinical > Outcomes Research
Researchers examining post-Ebola syndrome have discovered ocular consequences, including a disease-associated retinal scar.
Genotyping hepatitis C patients with advanced cirrhosis could help predict improvement after treatment, according to research presented at Digestive Disease Week®.
In this interview, Joop Arends discusses his thoughts on the future of diagnosis and management of hepatitis C, and also gives us his highlights from ECCMID.
New research has investigated the burden of nontuberculosis mycobacterium pulmonary disease in Germany, discovering high mortality and financial burden.
This Editorial discusses a Health Economics and Outcomes Research (HEOR) approach to use a formal comparative effectiveness analysis and a network meta-analysis for both first- and second-line ART regimens for adults, adolescents and children.
John-Arne Røttingen discusses his role as founding CEO of the Coalition for Epidemic Preparedness Innovations (CEPI) and his thoughts on the importance of developing new vaccines for emerging threats.
Despite challenges and setbacks in the decades-long struggle to eradicate polio, effective vaccines, evidence-based policy and global cooperation have brought the world closer to achieving polio eradication than ever before.